标题
SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML
作者
关键词
-
出版物
ONCOGENE
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-27
DOI
10.1038/s41388-023-02840-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The KMT2A recombinome of acute leukemias in 2023
- (2023) C. Meyer et al. LEUKEMIA
- High Throughput Fluorescence-Based In Vitro Experimental Platform for the Identification of Effective Therapies to Overcome Tumour Microenvironment-Mediated Drug Resistance in AML
- (2023) Yoana Arroyo-Berdugo et al. Cancers
- RAS and PP2A activities converge on epigenetic gene regulation
- (2023) Anna Aakula et al. Life Science Alliance
- Identification of a c-MYB-directed therapeutic for acute myeloid leukemia
- (2022) Katherine Clesham et al. LEUKEMIA
- Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic
- (2022) Dongxu Li et al. ONCOGENE
- Direct targeted therapy for MLL‐fusion‐driven high‐risk acute leukaemias
- (2022) Sandra Cantilena et al. Clinical and Translational Medicine
- Thirty years of SET/TAF1β/I2PP2A: from the identification of the biological functions to its implications in cancer and Alzheimer’s disease
- (2022) Antonella Di Mambro et al. BIOSCIENCE REPORTS
- The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer
- (2021) Stephin J. Vervoort et al. CELL
- Nuclear FGFR2 Interacts with the MLL-AF4 Oncogenic Chimera and Positively Regulates HOXA9 Gene Expression in t(4;11) Leukemia Cells
- (2021) Tiziana Fioretti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SET‐NUP214 and MLL cooperatively regulate the promoter activity of the HoxA10 gene
- (2021) Sadik Cigdem et al. GENES TO CELLS
- HOXA9 promotes MYC-mediated leukemogenesis by maintaining gene expression for multiple anti-apoptotic pathways
- (2021) Ryo Miyamoto et al. eLife
- Drug Repurposing for Targeting Acute Leukemia With KMT2A (MLL)—Gene Rearrangements
- (2021) Alexia Tsakaneli et al. Frontiers in Pharmacology
- The MTT Assay: Utility, Limitations, Pitfalls, and Interpretation in Bulk and Single-Cell Analysis
- (2021) Mahshid Ghasemi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Direct Phosphorylation and Stabilization of MYC by Aurora B Kinase Promote T-cell Leukemogenesis
- (2020) Jue Jiang et al. CANCER CELL
- Phosphoproteome and drug response effects mediated by the three Protein Phosphatase 2A inhibitor proteins CIP2A, SET and PME-1
- (2020) Otto Kauko et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Reconstructing kinase network topologies from phosphoproteomics data reveals cancer-associated rewiring
- (2020) Maruan Hijazi et al. NATURE BIOTECHNOLOGY
- A new regulatory mechanism of protein phosphatase 2A activity via SET in acute myeloid leukemia
- (2020) Elena Arriazu et al. Blood Cancer Journal
- Novel therapeutic strategies for MLL-rearranged leukemias
- (2020) Nok-Hei Mickey Wong et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- The NMR-based characterization of the FTY720-SET complex reveals an alternative mechanism for the attenuation of the inhibitory SET-PP2A interaction
- (2019) Ryan M. De Palma et al. FASEB JOURNAL
- Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions
- (2019) Anthony K. N. Chan et al. Frontiers in Cell and Developmental Biology
- Crosstalk between 14-3-3θ and AF4 enhances MLL-AF4 activity and promotes leukemia cell proliferation
- (2019) Tiziana Fioretti et al. CELLULAR ONCOLOGY
- FTY720 induces non-canonical phosphatidylserine externalization and cell death in acute myeloid leukemia
- (2019) Megan M. Young et al. Cell Death & Disease
- A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity
- (2019) Carmen Vicente et al. CANCER LETTERS
- HBO1 is required for the maintenance of leukaemia stem cells
- (2019) Laura MacPherson et al. NATURE
- SET Oncogene is Upregulated in Pediatric Acute Lymphoblastic Leukemia
- (2018) Sema Sirma Ekmekci et al. TUMORI
- PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas
- (2018) Yuan Ren et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting acute myeloid leukemia by drug-induced c-MYB degradation
- (2017) V Walf-Vorderwülbecke et al. LEUKEMIA
- MLL-Rearranged Leukemias—An Update on Science and Clinical Approaches
- (2017) Amanda C. Winters et al. Frontiers in Pediatrics
- Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsin
- (2016) M N Cruickshank et al. LEUKEMIA
- Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activation
- (2016) A N McCracken et al. LEUKEMIA
- Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival
- (2016) Daibiao Xiao et al. MOLECULAR CELL
- MYC-dependent recruitment of RUNX1 and GATA2 on the SET oncogene promoter enhances PP2A inactivation in acute myeloid leukemia
- (2016) Raffaella Pippa et al. Oncotarget
- The emerging role of FTY720 (Fingolimod) in cancer treatment
- (2016) Christopher White et al. Oncotarget
- Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A
- (2015) F. Zonta et al. BLOOD
- The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia
- (2015) A. Baker et al. CANCER RESEARCH
- The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias
- (2015) Vincent-Philippe Lavallée et al. NATURE GENETICS
- Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors
- (2015) Maria Teresa Esposito et al. NATURE MEDICINE
- PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects
- (2015) Raúl Rincón et al. Oncotarget
- From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies
- (2015) Maria Ciccone et al. Frontiers in Oncology
- Effect of FTY720 on the SET–PP2A complex in acute myeloid leukemia; SET binding drugs have antagonistic activity
- (2014) R Pippa et al. LEUKEMIA
- Stable SET knockdown in head and neck squamous cell carcinoma promotes cell invasion and the mesenchymal-like phenotype in vitro, as well as necrosis, cisplatin sensitivity and lymph node metastasis in xenograft tumor models
- (2014) Lays M Sobral et al. Molecular Cancer
- Targeting Inhibitors of the Tumor Suppressor PP2A for the Treatment of Pancreatic Cancer
- (2014) Amy S. Farrell et al. MOLECULAR CANCER RESEARCH
- PP2A Inhibition Is a Common Event in Colorectal Cancer and Its Restoration Using FTY720 Shows Promising Therapeutic Potential
- (2014) I. Cristobal et al. MOLECULAR CANCER THERAPEUTICS
- FTY720 Induces Apoptosis of M2 Subtype Acute Myeloid Leukemia Cells by Targeting Sphingolipid Metabolism and Increasing Endogenous Ceramide Levels
- (2014) Limin Chen et al. PLoS One
- Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer
- (2014) M. Janghorban et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oncogenic fusion proteins expressed in immature hematopoietic cells fail to recapitulate the transcriptional changes observed in human AML
- (2014) N Rapin et al. Oncogenesis
- PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells
- (2013) Paolo Neviani et al. JOURNAL OF CLINICAL INVESTIGATION
- Protein phosphatase 2A: a target for anticancer therapy
- (2013) Danilo Perrotti et al. LANCET ONCOLOGY
- Insights in dynamic kinome reprogramming as a consequence of MEK inhibition in MLL-rearranged AML
- (2013) K R Kampen et al. LEUKEMIA
- Ser9 phosphorylation causes cytoplasmic detention of I2PP2A/SET in Alzheimer disease
- (2013) Guang Yu et al. NEUROBIOLOGY OF AGING
- Kinase-Substrate Enrichment Analysis Provides Insights into the Heterogeneity of Signaling Pathway Activation in Leukemia Cells
- (2013) P. Casado et al. Science Signaling
- FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cells
- (2011) Craig T. Wallington-Beddoe et al. Autophagy
- SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target
- (2011) D. J. Christensen et al. BLOOD
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
- (2011) Kathrin M. Bernt et al. CANCER CELL
- Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia
- (2011) I. Cristobal et al. HAEMATOLOGICA
- PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect
- (2011) I Cristóbal et al. LEUKEMIA
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
- (2011) Mark A. Dawson et al. NATURE
- Targeting SET/I2PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy
- (2011) C H Switzer et al. ONCOGENE
- Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT+ Cancers
- (2010) K. G. Roberts et al. CANCER RESEARCH
- Association of a Leukemic Stem Cell Gene Expression Signature With Clinical Outcomes in Acute Myeloid Leukemia
- (2010) Andrew J. Gentles JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hierarchical Maintenance of MLL Myeloid Leukemia Stem Cells Employs a Transcriptional Program Shared with Embryonic Rather Than Adult Stem Cells
- (2009) Tim C.P. Somervaille et al. Cell Stem Cell
- HOXA9 is required for survival in human MLL-rearranged acute leukemias
- (2008) J. Faber et al. BLOOD
- An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia
- (2008) K. H. Metzeler et al. BLOOD
- The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia
- (2008) P. Van Vlierberghe et al. BLOOD
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started